271 related articles for article (PubMed ID: 27676693)
1. Cancer stem cells: A product of clonal evolution?
van Niekerk G; Davids LM; Hattingh SM; Engelbrecht AM
Int J Cancer; 2017 Mar; 140(5):993-999. PubMed ID: 27676693
[TBL] [Abstract][Full Text] [Related]
2. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: in the line of fire.
Alison MR; Lin WR; Lim SM; Nicholson LJ
Cancer Treat Rev; 2012 Oct; 38(6):589-98. PubMed ID: 22469558
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell: fundamental experimental pathological concepts and updates.
Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
[TBL] [Abstract][Full Text] [Related]
5. Die hard: are cancer stem cells the Bruce Willises of tumor biology?
Fábián A; Barok M; Vereb G; Szöllosi J
Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297
[TBL] [Abstract][Full Text] [Related]
6. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
Prick J; de Haan G; Green AR; Kent DG
Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
Najafi M; Mortezaee K; Ahadi R
Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.
Kilmister EJ; Tan ST
J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on targeting effect and regulating mechanisms of the stemness of cancer stem cells].
Ma HY; He M; Wei MJ
Yao Xue Xue Bao; 2016 Feb; 51(2):189-96. PubMed ID: 29856198
[TBL] [Abstract][Full Text] [Related]
11. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
Borst P
Open Biol; 2012 May; 2(5):120066. PubMed ID: 22724067
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
13. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
14. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells--the current status of an old concept: literature review and clinical approaches.
Fulawka L; Donizy P; Halon A
Biol Res; 2014 Dec; 47(1):66. PubMed ID: 25723910
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in breast cancer.
Dittmer J; Rody A
Histol Histopathol; 2013 Jul; 28(7):827-38. PubMed ID: 23468411
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
